Company / Cash & Equivalents
Healthcare Triangle, Inc. Cash & Equivalents History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$20.0K
FY2025
5-year range
$20.0K / $1.8M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $1M to $20,000 over the past 2 years.
Based on SEC 10-K filings.
$20,000 in FY2025 with a 3-year CAGR of -75.4%.
Declined from $1M to $20,000 over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -75.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -75.4%, indicating a declining trend.
- In FY2025, cash & equivalents increased 0.0% year-over-year.
- Peak cash & equivalents was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -3.81 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.0K | +0.0% |
| FY2024 | $20.0K | -98.5% |
| FY2023 | $1.3M | +0.0% |
| FY2022 | $1.3M | -24.2% |
| FY2021 | $1.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026